Abstract |
Our previous studies identified the extract of Beta vulgaris (beetroot), commercially also known as betanin, as a potent cancer chemopreventive agent in both in vitro Epstein-Barr early antigen activation assay and in an in vivo two-stage mouse lung and skin carcinogenesis. To explore this issue further, we have now investigated its cancer chemopreventive potentials in three different chemical carcinogen initiation-promotion experimental tumor models in mice. Following tumor initiation with 390 nmol of 7,12-dimethylbenz(a)anthracene (DMBA) in 100 microl of acetone, the mouse skin tumor promotion with 3430 J/m(2) of ultraviolet light-B (UV-B) as well as splenomegaly was significantly inhibited by oral administration of 0.0025% betanin. At the same dose, betanin also afforded significant protection in the mouse skin cancer model following the topical application of 390 nmol of (+/-)-(E)-4-methyl-2-[(E)-hydroxyamino]-5-nitro-6-methoxy-3- hexanamide (NOR-1) in 100 microl of acetone and promoted by topical administration of 1.7 nmol of 12-O-tetradecanoylphorbol-13-acetate (TPA). In the two-stage model of hepatocarcinogenesis in mice with N-nitrosodiethylamine (DEN, 30 mg/kg) as the initiator and phenobarbital as the promoter, oral administration of 0.0025% betanin also showed a very significant inhibition of both the incidence and multiplicity of the liver tumors. These findings along with our initial reports suggest that betanin which is a regularly consumed natural product colorant is an effective cancer chemopreventive agent in mice. The most interesting observation is that the cancer chemopreventive effect was exhibited at a very low dose used in the study and thus indicating that beetroot warrants more attention for possible human applications in the control of malignancy.
|
Authors | Govind J Kapadia, Magnus A Azuine, Rajagopalan Sridhar, Yoko Okuda, Atsushi Tsuruta, Eiichiro Ichiishi, Teruo Mukainake, Midori Takasaki, Takao Konoshima, Hoyoku Nishino, Harukuni Tokuda |
Journal | Pharmacological research
(Pharmacol Res)
Vol. 47
Issue 2
Pg. 141-8
(Feb 2003)
ISSN: 1043-6618 [Print] Netherlands |
PMID | 12543062
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- (+-)-E-4-methyl-2-((E)-hydroxylamino)-5-nitro-6-methoxy-3-hexanamide
- Anticarcinogenic Agents
- Betacyanins
- Carcinogens
- Hydroxylamines
- Indoles
- Plant Extracts
- Diethylnitrosamine
- 9,10-Dimethyl-1,2-benzanthracene
- betanin
- Tetradecanoylphorbol Acetate
- Phenobarbital
|
Topics |
- 9,10-Dimethyl-1,2-benzanthracene
(antagonists & inhibitors, toxicity)
- Animals
- Anticarcinogenic Agents
(pharmacology)
- Beta vulgaris
(chemistry)
- Betacyanins
- Body Weight
(drug effects)
- Carcinogens
(antagonists & inhibitors, toxicity)
- Diethylnitrosamine
(antagonists & inhibitors, toxicity)
- Dose-Response Relationship, Drug
- Female
- Hydroxylamines
(antagonists & inhibitors, toxicity)
- Indoles
(pharmacology)
- Liver Neoplasms, Experimental
(chemically induced, prevention & control)
- Mice
- Mice, Inbred ICR
- Neoplasms, Radiation-Induced
(prevention & control)
- Phenobarbital
(antagonists & inhibitors, toxicity)
- Plant Extracts
(pharmacology)
- Plant Roots
(chemistry)
- Skin Neoplasms
(chemically induced, prevention & control)
- Tetradecanoylphorbol Acetate
(antagonists & inhibitors, toxicity)
- Ultraviolet Rays
|